# Treatment of the Dumping Syndrome With Lanreotide Autogel®

> **NCT00543179** · PHASE4 · UNKNOWN · sponsor: **Radboud University Medical Center**

## Conditions studied

- Dumping Syndrome

## Interventions

- **DRUG:** Somatuline (Lanreotide Autogel®)

## Key facts

- **NCT ID:** NCT00543179
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543179, "Treatment of the Dumping Syndrome With Lanreotide Autogel®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00543179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*